CRANDELL KEITH

CIK 1219039
Transactions on file
18
Open-market buys
6
Win rate (buys)
75%
4 scored
Avg % since filing (buys)
+8.9%

Tickers traded

Recent activity

FiledTxn dateIssuerRolesCodeSharesValue% since FilingFiling
2026-07-062026-07-01BOLD
Boundless Bio, Inc.
10%
Sale16,000$39.8K+0.4%open →
2026-07-062026-07-01BOLD
Boundless Bio, Inc.
10%
Exer.16,000$16.5K+142.7%open →
2026-06-242026-06-22KARD
Kardigan, Inc.
Director10%
Buy1,250,000$20.00M+30.1%open →
2026-06-222026-06-17KARD
Kardigan, Inc.
C13,792,035$0.00open →
2026-06-122026-06-10MASS
908 Devices Inc.
Exer.14,083$0.00open →
2025-02-032025-02-03MTSR
Metsera, Inc.
10%
C7,523,682open →
2025-02-032025-02-03MTSR
Metsera, Inc.
10%
Buy1,432,224$25.78Mopen →
2025-02-032025-02-03MTSR
Metsera, Inc.
10%
Buy789,998$14.22Mopen →
2025-02-032025-02-03MTSR
Metsera, Inc.
10%
C16,006,949open →
2025-02-072025-02-05TWST
Twist Bioscience Corp
Director
Grant4,472$0.00open →
2025-06-132025-06-11MASS
908 Devices Inc.
Director10%
Exer.11,364open →
2026-05-042026-05-04SPTX
Seaport Therapeutics, Inc.
Buy1,100,000$19.80M+21.9%open →
2026-05-042026-05-04SPTX
Seaport Therapeutics, Inc.
C2,681,265$0.00open →
2026-05-042026-05-04SPTX
Seaport Therapeutics, Inc.
C2,513,686$0.00open →
2025-11-142025-11-13MTSR
Metsera, Inc.
Director10%
Disp.8,313,680$0.00open →
2025-11-142025-11-13MTSR
Metsera, Inc.
Director10%
Disp.18,503,128$0.00open →
2025-10-292025-10-27NMRA
Neumora Therapeutics, Inc.
10%
Buy1,915,700$5.00M-37.2%open →
2025-08-012025-08-01PRME
Prime Medicine, Inc.
10%
Buy3,030,300$10.00M+20.9%open →